Kaken Pharmaceutical Co Ltd 2019 Integrated Report
The report presents KAKEN's FY2018 performance for the year ended March 31, 2019, including consolidated net sales of ¥94,165 million. It highlights environmental efforts at the Shizuoka site and Kyoto Drug Research Center, including FY2018 waste produced of 923 tons and CO2 emissions of 22,493 t-CO2. KAKEN also reports a company-set target to reduce CO2 emissions by 23% in FY2020 versus FY2005.
Company: Kaken Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Integrated Report
Pages: 78
Back to company
Kaken Pharmaceutical Co Ltd
Corporate Report
The report presents KAKEN's FY2018 performance for the year ended March 31, 2019, including consolidated net sales of ¥94,165 million. It highlights environmental efforts at the Shizuoka site and Kyoto Drug Research Center, including FY2018 waste produced of 923 tons and CO2 emissions of 22,493 t-CO2. KAKEN also reports a company-set target to reduce CO2 emissions by 23% in FY2020 versus FY2005.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Employees